Axon Enterprise, Inc $AXON Shares Sold by Rathbones Group PLC

Rathbones Group PLC decreased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 3.8% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 32,730 shares of the biotechnology company’s stock after selling 1,302 shares during the period. Rathbones Group PLC’s holdings in Axon Enterprise were worth $23,488,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Stone House Investment Management LLC acquired a new position in Axon Enterprise in the third quarter valued at approximately $29,000. New Millennium Group LLC purchased a new position in Axon Enterprise in the third quarter worth approximately $29,000. Darwin Wealth Management LLC acquired a new stake in Axon Enterprise during the second quarter worth $37,000. Root Financial Partners LLC purchased a new stake in Axon Enterprise in the third quarter valued at $34,000. Finally, Elevation Point Wealth Partners LLC purchased a new stake in Axon Enterprise in the second quarter valued at $56,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 revenue and bookings beat expectations — Axon reported quarterly revenue of ~$796.7M (up ~38.5% YoY) and said bookings were at record levels, driven by recurring software/services and AI products; investors are rewarding the growth narrative. Read More.
• Positive Sentiment: AI and acquisitions broaden the TAM — Axon is rolling out AI tools (Draft One) and expanding into emergency communications via buys like Carbyne and Prepared, pushing the company from hardware into a higher‑margin, recurring‑revenue public‑safety platform. Read More.
• Positive Sentiment: Hardware momentum in Connected Devices — demand for TASER 10, Axon Body 4 and counter‑drone solutions boosted device sales, helping current revenue strength and cross‑sell into Axon Cloud subscriptions. Read More.
• Neutral Sentiment: Street attention and bull narratives — multiple outlets and bullish newsletters have flagged Axon as a pick, increasing retail/institutional focus but also raising expectations. Read More.
• Negative Sentiment: Profitability collapsed despite revenue growth — quarterly net income plunged (reported near break‑even), compressing EPS and margins; that raises near‑term profitability and margin recovery questions. Read More.
• Negative Sentiment: Insider selling — Axon’s CAO sold 1,500 shares (~$860k), which may be viewed negatively by some investors even though the remaining insider stake remains material. Read More.
• Negative Sentiment: Analysts trimmed targets — some firms cut price targets (Morgan Stanley, Barclays) even as many maintain buy/overweight positions, signaling debate about valuation vs. execution. Read More.
• Negative Sentiment: High valuation and execution risk — AXON trades at a very high P/E, leaving the stock sensitive to execution on margin recovery, successful AI monetization and integration of acquisitions. Read More.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Barclays lowered their price target on Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. William Blair restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Royal Bank Of Canada decreased their target price on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 25th. Craig Hallum reaffirmed a “buy” rating and set a $820.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 25th. Finally, Piper Sandler dropped their price target on shares of Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating for the company in a research report on Wednesday, February 25th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $762.93.

Axon Enterprise Trading Up 0.6%

Shares of NASDAQ AXON opened at $574.01 on Monday. Axon Enterprise, Inc has a twelve month low of $396.41 and a twelve month high of $885.91. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. The stock has a fifty day simple moving average of $536.08 and a 200-day simple moving average of $616.86. The stock has a market capitalization of $46.15 billion, a PE ratio of 377.64, a PEG ratio of 12.25 and a beta of 1.46.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The firm had revenue of $796.72 million for the quarter, compared to analyst estimates of $755.29 million. During the same quarter in the prior year, the company earned $2.08 EPS. Axon Enterprise’s revenue was up 38.5% on a year-over-year basis. On average, equities analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other news, insider Isaiah Fields sold 2,000 shares of the stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the sale, the insider owned 55,588 shares of the company’s stock, valued at approximately $29,740,135.88. This represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the completion of the transaction, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at approximately $1,546,240,339.28. The trade was a 0.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 26,634 shares of company stock valued at $14,963,095 over the last three months. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.